Drug Discovery

We have a fully integrated drug discovery and preclinical development unit focused on identifying innovative compounds in pulmonology and fibrotic diseases. This group uses computational and structural approaches in the rational design and optimization of drug candidates. Fully developed capabilities for preclinical development allow the group to advance compounds to the IND stage. In addition, the group is responsible for the characterization of the mechanisms of action and the determination of the biological, toxicology and pharmacology profiles of our product development candidates.